NCT05516342

Brief Summary

The proposed Phase 2 project will involve the further development and evaluation of LEAD IT!, which is a tablet-based app designed to enable persons with dementia to lead activities for their peers (i.e., other persons with dementia). The study will examine the clinical outcomes of long-term use of the app by both Resident Leaders (RLs) and Resident Players (RPs). The Specific Aims of the proposed Phase 2 project are to:

  1. 1.Develop improved Beta 1 and Beta 2 Versions of LEAD IT! with sufficient content to facilitate six activities twice per week for 4.5 months.
  2. 2.Examine the extent to which RLs are able to serve as leaders while using LEAD IT!
  3. 3.Examine the effects of resident-led LEAD IT! programming on RPs.
  4. 4.Examine PWD and staff satisfaction with LEAD IT!

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
182

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 10, 2020

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

August 10, 2022

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 25, 2022

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 11, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 11, 2023

Completed
1.5 years until next milestone

Results Posted

Study results publicly available

December 2, 2024

Completed
Last Updated

December 2, 2024

Status Verified

May 1, 2024

Enrollment Period

2.6 years

First QC Date

August 10, 2022

Results QC Date

May 22, 2024

Last Update Submit

October 14, 2024

Conditions

Keywords

psychosocialsocialnon-pharmacological intervention

Outcome Measures

Primary Outcomes (5)

  • Change From Baseline to Treatment for Constructive Engagement on the Menorah Park Engagement Scale [Time Frame: Baseline (Month 1) and Treatment (Months 2, 3, and 4)

    Constructive Engagement on the Menorah Park Engagement Scale is defined as doing or commenting on something related to the target activity. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Constructive Engagement is zero (0) and the maximum score is two (2). Higher scores represent a better outcome.

    Baseline (Month 1) and Treatment (Months 2, 3, and 4)

  • Change From Baseline to Treatment for Passive Engagement on the Menorah Park Engagement Scale

    Passive Engagement on the Menorah Park Engagement Scale is defined as listening or watching something related to the target activity.During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Passive Engagement is zero (0) and the maximum score is two (2). Higher scores represent a better outcome..

    Baseline (Month 1) and Treatment (Months 2, 3, and 4)

  • Change From Baseline to Treatment for Other Engagement on the Menorah Park Engagement Scale

    Other Engagement on the Menorah Park Engagement Scale is defined as doing, commenting, listening, or watching something NOT related to the target activity. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Other Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.

    Baseline (Month 1) and Treatment (Months 2, 3, and 4)

  • Change From Baseline to Treatment for Non Engagement on the Menorah Park Engagement Scale

    Non-Engagement on the Menorah Park Engagement Scale is defined as sleeping and/or staring into space. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Non-Engagement is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.

    Baseline (Month 1) and Treatment (Months 2, 3, and 4)

  • Change From Baseline to Treatment for Pleasure on the Menorah Park Engagement Scale

    Pleasure on the Menorah Park Engagement Scale is defined as clearly observable laughing or smiling. During baseline, multiple observations of "standard" activities were observed and a single mean score was calculated for all sessions observed during that month. Then, again, during treatment, multiple treatment activity sessions were observed over the course of three months (Months 2, 3, and 4) and a single mean score was calculated. The minimum value for Pleasure is zero (0) and the maximum score is two (2). Lower scores represent a better outcome.

    Baseline (Month 1) and Treatment (Months 2, 3, and 4)

Secondary Outcomes (4)

  • Change From Baseline to Treatment on Dementia Related Quality of Life (DEMQOL)

    Baseline (Month 1) and Post-Treatment (Month 4)

  • Change From Baseline to Treatment on the Neuropsychiatric Inventory-Nursing Home (NPI-NH), Frequency x Severity Score (FxS)

    Baseline (Month 1) and Post-Treatment (Month 4)

  • Change From Baseline to Treatment on the Geriatric Depression Scale-Short Form (GDS-SF)

    Baseline (Month 1) and Post-Treatment (Month 4)

  • Change From Baseline to Treatment on the Cohen Mansfield Agitation Inventory (CMAI)

    Baseline (Month 1) and Post-Treatment (Month 4)

Study Arms (2)

Experimental: Experimental, LEAD IT! Programming

EXPERIMENTAL

Participants in the Experimental / LEAD IT! arm will take part in LEAD IT! programming for 18 weeks. The programming will occur twice per week, for a total of 36 sessions.

Behavioral: LEAD IT! Programming

No Intervention: Control, Standard Care / Programming

NO INTERVENTION

Participants in the Control arm will receive standard care / programming.

Interventions

LEAD IT! is an intervention that enables persons with dementia to lead activities for their peers. The activities take place on tablets.

Experimental: Experimental, LEAD IT! Programming

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Must reside in an Assisted Living Facility or NH
  • Must be at least 65 years old
  • Must speak and read English
  • Must have a clinical diagnosis of dementia (any type).
  • Resident-players must score at least five on the Mini-Mental State Examination (MMSE)
  • Resident-leaders must score at least 13 on the MMSE
  • Resident-leaders must possess at least 70% of the characteristics of successful leaders, based upon the I'm Still Here Skills Inventory, Short Edition, Modified

You may not qualify if:

  • Must be at least 18 years old
  • Must speak English
  • n/a

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Hearthstone Institute, LLC

Winchester, Massachusetts, 01890, United States

Location

MeSH Terms

Conditions

Dementia, VascularAlzheimer DiseaseMixed Dementias

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesIntracranial ArteriosclerosisIntracranial Arterial DiseasesDementiaLeukoencephalopathiesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesNeurocognitive DisordersMental DisordersTauopathiesNeurodegenerative Diseases

Results Point of Contact

Title
Michael Skrajner
Organization
Hopeful Aging

Study Officials

  • Michael Skrajner, MA

    Hearthstone

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two quasi-experiments will be conducted. Experiment #1 will test the Beta 1 Version of the app with 24 PWD and use a pre-post design. Experiment #1's goal is to examine and improve new activities and to make final changes to the overall app structure. Experiment #2, which will test Beta 2, will be a cluster randomized trial (CRT), consisting of pre- and post-intervention measurements of two nonequivalent groups: a Treatment Group (TG)-i.e. 48 PWD who receive the intervention - and a Control Group (CG)- i.e., 48 PWD receiving standard programming / care. Since Experiment #2 will occur after all tweaking is complete, it will represent the definitive trial of LEAD IT!'s proximal and distal effects.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 10, 2022

First Posted

August 25, 2022

Study Start

November 10, 2020

Primary Completion

June 11, 2023

Study Completion

June 11, 2023

Last Updated

December 2, 2024

Results First Posted

December 2, 2024

Record last verified: 2024-05

Locations